Tesamorelin (20mg) Product Information
A single-component research material supplied for controlled research environments. Tesamorelin (20 mg) is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus, widely used in research exploring GHRH receptor signaling, somatotroph axis regulation, and pulsatile growth hormone secretion dynamics in model systems. Composition Tesamorelin (modified GHRH(1-44) analog): 20 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of GHRH receptor binding kinetics and downstream somatotroph signaling cascades in cell culture studies Evaluation of pulsatile growth hormone release patterns and IGF-1 axis modulation in in vitro and in vivo experimental models Assessment of lipid metabolism biomarkers and visceral adipose tissue regulation under controlled laboratory conditions Stability and bioactivity characterization of lyophilized Tesamorelin under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability; batch traceable Tamper-evident seal; lot & test date on each vial No MOQ for online orders Bulk orders for physical locations start at 25-unit minimum
